大连标准化公共服务平台|国际技术法规

委员会条例(EU) 2017/1510，就CMR物质，修订关于化学品的注册、评估、授权和限制(REACH)的欧洲议会和理事会条例(EC) No 1907/2006的附件XVII

技术法规类型：欧盟Eurlex法规来源：tbtmap

EURLEX ID：32017R1510

OJ编号：OJ L 224, 31.8.2017, p. 110–114 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

中文标题：委员会条例(EU) 2017/1510，就CMR物质，修订关于化学品的注册、评估、授权和限制(REACH)的欧洲议会和理事会条例(EC) No 1907/2006的附件XVII

原文标题：Commission Regulation (EU) 2017/1510 of 30 August 2017 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance. )

生效日期：2017-09-20

废止日期：9999-12-31

法规全文：查看欧盟官方文件

31.8.2017

Official Journal of the European Union

L 224/110

COMMISSION REGULATION (EU) 2017/1510

of 30 August 2017

amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (1), and in particular Article 68(2) thereof,

Whereas:

(1)

Entries 28, 29 and 30 of Annex XVII to Regulation (EC) No 1907/2006 prohibit the placing on the market or use for supply to the general public of substances that are classified as carcinogenic, mutagenic or reproductive toxicant (CMR), category 1A or 1B, and of mixtures containing such substances in specified concentrations. The substances concerned are listed in Appendices 1 to 6 to that Annex.

(2)	Substances are classified as CMR in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council (2) and are listed in Part 3 of Annex VI to that Regulation.

(3)

Since Appendices 1 to 6 to Annex XVII to Regulation (EC) No 1907/2006 were last updated to reflect new classifications of substances as CMR under Regulation (EC) No 1272/2008, Part 3 of Annex VI to the latter has been amended by Commission Regulations (EU) No 605/2014 (3), (EU) 2015/1221 (4) and (EU) 2016/1179 (5).

(4)	As operators may apply the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008 at an earlier date, they should be able to apply the provisions of this Regulation earlier, on a voluntary basis.

(5)	Regulation (EC) No 1907/2006 should be amended accordingly.

(6)	The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Article 1

Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.

Article 2

1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

2. It shall apply from the date of entry into force, with the exception of:

—	paragraphs (1), (2) and (3) of the Annex, which shall apply on 1 March 2018, and

—

paragraph (4)(a) of the Annex which shall apply on 1 March 2018 to the extent that it relates to the following substances:

bisphenol A; [phenol, dodecyl-, branched]; [phenol, 2-dodecyl-, branched]; [phenol, 3-dodecyl-, branched]; [phenol, 4-dodecyl-, branched]; [phenol, (tetrapropenyl) derivatives]; chlorophacinone (ISO); coumatetralyl (ISO); difenacoum (ISO); flocoumafen (ISO); disodium octaborate anhydrous; disodium octaborate tetrahydrate; bromadiolone (ISO); difethialone; [perfluorononan-1-oic acid, and its sodium and ammonium salts]; dicyclohexyl phthalate and triflumizole (ISO).

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 30 August 2017.

For the Commission

The President

Jean-Claude JUNCKER

(1) OJ L 396, 30.12.2006, p. 1.

(2) Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).

(3) Commission Regulation (EU) No 605/2014 of 5 June 2014 amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 167, 6.6.2014, p. 36).

(4) Commission Regulation (EU) 2015/1221 of 24 July 2015 amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, for the purposes of its adaptation to technical and scientific progress (OJ L 197, 25.7.2015, p. 10).

(5) Commission Regulation (EU) 2016/1179 of 19 July 2016 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 195, 20.7.2016, p. 11).

ANNEX

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:

(1)

in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:

‘1,2-dichloropropane; propylene dichloride	602-020-00-0	201-152-2	78-87-5
e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).]	014-046-00-4	—	—’

(2)

in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:

‘3,7-dimethylocta-2,6-dienenitrile

608-067-00-3

225-918-0

5146-66-7’

(3)

in Appendix 5,

(a)

the following entries are inserted in the table in order of the index numbers set out therein:

‘brodifacoum (ISO);

4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin

607-172-00-1

259-980-5

56073-10-0

lead powder;

[particle diameter < 1 mm]

082-013-00-1

231-100-4

7439-92-1

lead massive:

[particle diameter ≥ 1 mm]

082-014-00-7

231-100-4

7439-92-1’

(b)

the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:

‘warfarin (ISO);

4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1]

(S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2]

(R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3]

607-056-00-0

201-377-6 [1]

226-907-3 [2]

226-908-9 [3]

81-81-2 [1]

5543-57-7 [2]

5543-58-8 [3]’

(4)

in Appendix 6,

(a)

the following entries are inserted in the table in order of the index numbers set out therein:

‘tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol	603-061-00-7	202-625-6	97-99-4
gallium arsenide	031-001-00-4	215-114-8	1303-00-0
Tributyltin compounds, with the exception of those specified elsewhere in this Annex	050-008-00-3	—	—
1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear	607-710-00-5	271-093-5	68515-50-4
imidazole	613-319-00-0	206-019-2	288-32-4
bisphenol A; 4,4′-isopropylidenediphenol	604-030-00-0	201-245-8	80-05-7
phenol, dodecyl-, branched; [1] phenol, 2-dodecyl-, branched; [2] phenol, 3-dodecyl-, branched; [3] phenol, 4-dodecyl-, branched; [4] phenol, (tetrapropenyl) derivatives [5]	604-092-00-9	310-154-3 [1] - [2] - [3] - [4] - [5]	121158-58-5 [1] - [2] - [3] 210555-94-5 [4] 74499-35-7 [5]
chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione	606-014-00-9	223-003-0	3691-35-8
coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin	607-059-00-7	227-424-0	5836-29-3
difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin	607-157-00-X	259-978-4	56073-07-5
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin	607-375-00-5	421-960-0	90035-08-8
disodium octaborate anhydrous; [1] disodium octaborate tetrahydrate [2]	005-020-00-3	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]
bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one	607-716-00-8	249-205-9	28772-56-7
difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one	607-717-00-3	—	104653-34-1
perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] salts	607-718-00-9	206-801-3 [1] - [2] - [3]	375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]
dicyclohexyl phthalate	607-719-00-4	201-545-9	84-61-7
triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine	612-289-00-6	—	68694-11-1’

(b)

the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:

‘flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione

613-166-00-X

—

103361-09-7’

附件:

P020181030451906148284.pdf
P020181030451906289772.html

标准托管

托管标准，您可以接收以下服务：

1 标准定期系统查新,若有最新版本,会以站内短信或邮件的形式通知用户；

2 随时在标准托管页面中查看到该条标准的最新状态；

3 若用户有在学习和科研中的需要，可以在标准托管页面中试阅标准；

4 企业如果需要上新产品,我院及时提供标准查询、采购等方面的支持；

5 为企业在标准制修订、企业良好行为创建以及标准化试点过程中遇到的困难,可联系我院指定相关专家负责进行指导帮助、提供政策咨询；

6 为企业提供标准化政策的解读、标准化知识的推广培训、标准自我公开声明、标准文献的免费查询、企业标准化体系建设等方面的标准化服务；

进入企业标准托管

标准查新

您可以通过编辑查新模板，批量查询指定标准集的最新情况。我们会通过查询，向您展示您所查询标准的：

1. 准确的标准号及标准名称(我们通过人工智能技术对您提交的标准号进行自动纠正)

2. 标准的最新状态(现行、废止或未发布)

3. 若标准已废止并被新标准替代，会反馈被替代的标准

4. 若您已托管此标准，便可以实时跟踪这个标准的最新状态

标准查新模板下载

标准查询

[[ c.nature | nature ]]

点击查看

[[ c.title ]]

[[ c.status ]]

大连标准化公共服务平台

版权：大连标准化研究院有限公司

地址：大连市中山区高原街56号

电话：0411-82740851